TJO-083

· Taejoon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TJO-083, covering 2022-04-26 to 2025-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients [Phase 3]